McDougal J S, Nicholson J K, Cross G D, Cort S P, Kennedy M S, Mawle A C
J Immunol. 1986 Nov 1;137(9):2937-44.
Human immunodeficiency virus (HIV), the retrovirus that causes the acquired immunodeficiency syndrome, is cytopathic for CD4+ T cells and binds to these cells via a complex of the 110,000 m.w. viral-envelope glycoprotein, gp110, and the CD4 molecule. We treated virus with several physical, chemical, and enzymic agents to determine their effect on the capacity of HIV to bind to the CD4+ T cell line, CEM. Reduction and alkylation (but not alkylation alone) and trypsin digestion (but not glycolytic enzyme digestions) of HIV destroyed its capacity to bind. If the tertiary protein structure conferred by disulfide bonding is not disrupted, the tertiary and secondary conformations dependent on noncovalent forces appear to be thermodynamically favored, because treatment with denaturants such as sodium dodecyl sulfate, 8 M urea, alcohol, or heat (56 degrees C or 65 degrees C for 30 min) followed by removal of the denaturants did not affect binding. Irreversible denaturation and loss of binding occurred after heating at 100 degrees C for 10 min. HIV binding to CD4+ T cells was inhibited either by murine monoclonal antibodies to the CD4 molecule or by human polyclonal or murine monoclonal antibodies to the gp110 molecule. On the basis of results of binding inhibition obtained with a panel of alpha-CD4 monoclonal antibodies, the receptor site for virus on the CD4 molecule was mapped to the amino-terminal portion of the molecule. Four candidate alpha-CD4 monoclonal antibodies that were potent inhibitors of virus binding (OKT4A, OKT4D, OKT4F, and Leu-3a) were examined for the possibility that their binding sites (idiotopes) might share structural and conformational similarity with the CD4-binding site on gp110. Polyclonal human or rabbit anti-HIV sera (that reacted with gp110 and inhibited virus binding) did not react with or inhibit the binding of these four alpha-CD4 monoclonal antibodies. Conversely, rabbit anti-idiotypic sera raised against each of the four candidate CD4 monoclonal antibodies did not react with virus or inhibit virus binding to CD4+ T cells. Further search or different approaches may yet yield an idiotype that is a structural and conformational "internal image" of the CD4-binding site of virus.
人类免疫缺陷病毒(HIV)是一种导致获得性免疫缺陷综合征的逆转录病毒,它对CD4+ T细胞具有细胞病变作用,并通过分子量为110,000的病毒包膜糖蛋白gp110与CD4分子的复合物与这些细胞结合。我们用几种物理、化学和酶试剂处理病毒,以确定它们对HIV与CD4+ T细胞系CEM结合能力的影响。HIV的还原和烷基化(但单独烷基化不行)以及胰蛋白酶消化(但糖酵解酶消化不行)破坏了其结合能力。如果由二硫键赋予的蛋白质三级结构未被破坏,那么依赖于非共价力的三级和二级构象在热力学上似乎是有利的,因为用十二烷基硫酸钠、8M尿素、酒精或加热(56℃或65℃ 30分钟)等变性剂处理后再去除变性剂不会影响结合。在100℃加热10分钟后发生不可逆变性并丧失结合能力。HIV与CD4+ T细胞的结合受到针对CD4分子的鼠单克隆抗体或针对gp110分子的人多克隆或鼠单克隆抗体的抑制。根据一组抗CD4单克隆抗体获得的结合抑制结果,病毒在CD4分子上的受体位点被定位到该分子的氨基末端部分。研究了四种作为病毒结合有效抑制剂的候选抗CD4单克隆抗体(OKT4A、OKT4D、OKT4F和Leu-3a),看它们的结合位点(独特型)是否可能与gp110上的CD4结合位点具有结构和构象相似性。人或兔抗HIV多克隆血清(与gp110反应并抑制病毒结合)不与这四种抗CD4单克隆抗体反应或抑制其结合。相反,针对这四种候选CD4单克隆抗体产生的兔抗独特型血清不与病毒反应或抑制病毒与CD4+ T细胞的结合。进一步的搜索或不同的方法可能会产生一种独特型,它是病毒CD4结合位点的结构和构象“内影像”。